Comments
Lupin Ltd announced that it has received a tentative approval from the US Food and Drug Administration (FDA) to market a generic version of the Prezista tablets, which are used for the treatment of HIV-1 infections. The generic version of the Janssen Products’ Prezista is the AB-rated generic equivalent of the original drug, the company said. Prezista tablets have annual sales of $12 billion in the US, Lupin added. Lupin would market the tablets in strengths of 75 mg, 150 mg, 300 mg, 400 mg, 600 mg and 800 mg.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.